Characterization of Dyslipidemia in Adolescent Obesity

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01988454

Enrollment

Registered

2013-11-20

Start date

2011-09-30

Completion date

2014-06-30

Last updated

2015-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The primary objective of this pilot study is to characterize the profile of lipoprotein, inflammatory, and metabolic markers of cardiovascular disease in obese adolescents as compared to normal-weight age-matched controls.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

13 Years to 19 Years

Healthy volunteers

Yes

Inclusion criteria

* Age 13-19 * BMI ≥25 (obese) or \<25 (normal weight)

Exclusion criteria

* Prior diagnosis of any eating disorder (e.g. anorexia or bulimia) * Prior diagnosis of any congenital lipid disorder (e.g. familial hypercholesterolemia) * Current use (or within past 6 months) of any lipid altering medications

Design outcomes

Primary

Measure	Time frame	Description
Comparison of biomarker profiles	Baseline	To characterize and compare lipoprotein, inflammation and metabolic markers in obese and normal weight adolescents.

Countries

United States

Outcome results